Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR6840 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EEF1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDOA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RCC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR2C2AP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPBD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CLASRP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
H2AFY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XRCC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZSWIM8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLPTM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBAP2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPNE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on